Lexicon Pharmaceuticals | Der Umsatz



Sales Veränderung Datum
Abbott USD 10.36B 610M 2025-03
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Alnylam Pharmaceuticals USD 594.19M 1.02M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Illumina USD 1.1B 24M 2024-12
Insmed USD 104.44M 11.02M 2024-12
Ironwood Pharmaceuticals USD 90.54M 1.05M 2024-12
J&J USD 21.89B 630M 2025-03
MacroGenics USD 19.35M 91.35M 2024-12
MannKind USD 76.78M 6.7M 2024-12
Merck USD 15.53B 94M 2025-03
Moderna USD 108M 858M 2025-03
Novartis USD 13.15B 330M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Thermo Fisher Scientific USD 10.36B 1.04B 2025-03
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
United Therapeutics USD 794.4M 58.5M 2025-03



Lexicon Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.